Where Stool is a Drug: International Approaches to Regulating the use of Fecal Microbiota for Transplantation.
Clicks: 257
ID: 86486
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
6.0
/100
20 views
20 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Regulatory agencies vary widely in their classification of FMT, with significant impact on patient access. This article conducts a global survey of national regulations and collates existing FMT classification statuses, ultimately suggesting that the human cell and tissue product designation best fits FMT's characteristics and that definitional objectives to that classification may be overcome.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (54 words).
Try re-searching for a better abstract.
| Reference Key |
scheeler2019wherethe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Scheeler, Alexandra; |
| Journal | the journal of law, medicine & ethics : a journal of the american society of law, medicine & ethics |
| Year | 2019 |
| DOI |
10.1177/1073110519897729
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.